Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. STKE, 27 March 2001
Vol. 2001, Issue 75, p. tw15
[DOI: 10.1126/stke.2001.75.tw15]

EDITORS' CHOICE

Neurobiology Blocking a Survival Pathway

In several neurodegenerative diseases, proteins that bear expanded polyglutamine repeats aggregate, a process that somehow leads to the demise of neurons. Nucifora et al. studied the interaction of aberrant versions of huntingtin (which is affected in Huntington's disease) and atrophin (which is affected in dentatorubral and pallidoluysian atrophy) that contain expanded polyglutamine repeats. These aberrant proteins avidly bound to the transcriptional coactivator CREB-binding protein (CBP) and prevented the transcription of target genes known to be crucial for neuronal survival.

F. C. Nucifora Jr., M. Sasaki, M. F. Peters, H. Huang, J. K. Cooper, M. Yamada, H. Takahashi, S. Tsuji, J. Troncoso, V. L. Dawson, T. M. Dawson, C. A. Ross, Interference by huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity. Science 291, 2423-2428 (2001). [Abstract] [Full Text]

Citation: Blocking a Survival Pathway. Sci. STKE 2001, tw15 (2001).


To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882